{"id":"W2955796504","doi":"10.1016/j.jval.2019.04.196","title":"PCN72 COST OF MANAGING METASTATIC BLADDER CANCER WITH THE INTRODUCTION OF IMMUNOTHERAPIES FROM A CANADIAN HEALTHCARE PERSPECTIVE","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Docetaxel; Pembrolizumab; Gemcitabine; Medicine; Atezolizumab; Oncology; Adverse effect; Internal medicine; Paclitaxel; Carboplatin; Prostate cancer; Metastatic Urothelial Carcinoma; Cisplatin; Bladder cancer; Cancer; Immunotherapy; Chemotherapy; Urothelial carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001445712,0.0005341351,0.0006458686,0.001773821,0.001658589,0.003059159,0.001252418,0.001570971,0.01170717],"category_scores_gemma":[0.009143324,0.0002892017,0.002190768,0.003308532,0.0007416575,0.0008237734,0.0009680027,0.00295279,0.0004707858],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.09294832,"about_ca_system_score_gemma":0.1131881,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9699573,"about_ca_topic_score_gemma":0.9783448,"domain_scores_codex":[0.9960508,0.0006362525,0.0001421881,0.0001665534,0.002023106,0.000981199],"domain_scores_gemma":[0.9933521,0.0006613428,0.0006478635,0.00005505579,0.003397344,0.001886237],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.003899871,0.000495566,0.1173633,0.003197446,0.003294694,0.001805437,0.001191924,0.03664669,0.00158429,0.091405,0.3315267,0.4075891],"study_design_scores_gemma":[0.0009962121,0.00112262,0.4282532,0.005937931,0.004415353,0.003197367,0.00476918,0.02163685,0.00112645,0.01257475,0.5154914,0.0004787095],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.2311406,0.105526,0.003057413,0.3814582,0.003075708,0.0003159459,0.03684494,0.0001828412,0.2383984],"genre_scores_gemma":[0.9184728,0.04567566,0.003031535,0.01159766,0.001360284,0.00008249326,0.006404547,0.00005724078,0.01331762],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.9070517,"threshold_uncertainty_score":0.6743904,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02545748039092295,"score_gpt":0.309615754214477,"score_spread":0.284158273823554,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}